Pharma Tips

Deviation Controls in Pharmaceutical R&D

By: Pharma Tips | Views: 1606 | Date: 17-Aug-2013

There are numerous examples of products that took many years to research, develop, get approved, and finally, marketed, due in part to inadequate controls during the R&D phases. Products have been approved but could not be marketed because they could not be manufactured reproducibly according to the conditions of approval. Review of data from preclinical, clinical, and other product studies and investigations into discrepant results from laboratory and clinical studies have revealed wide variations in produ

Deviation Controls in Pharmaceutical R&D

 

Background

There are numerous examples of products that took many years to research, develop, get approved, and finally, marketed, due in part to inadequate controls during the R&D phases. Products have been approved but could not be marketed because they could not be manufactured reproducibly according to the conditions of approval. Review of data from preclinical, clinical, and other product studies and investigations into discrepant results from laboratory and clinical studies have revealed wide variations in product formulation, handling, manufacturing, and testing.

In some cases, there have been so many issues to consider that causation of variability in study results could not be determined. In other cases, the lack of adequate documentation prevented any meaningful review or investigation because an accurate history of R&D could not be reconstructed.

Too often, it is virtually impossible to accurately trace the progression of a product’s development from initial phases of research, through multiple development phases, and finally, to the product submitted for approval and proposed for marketing. Sadly, since the review of product development typically occurs long after the work is completed, problems are identified late in the product life cycle and can result in redoing multiple studies.

Product Life Cycles

Various authors have written about product life cycles, which include, generally, the following phases: concept, planning, research and development, scale-up, launch, and maintenance. Applying the definition presented above, research can occur during any of the phases of a product’s life cycle although, admittedly, the R&D activities can vary in scope and extent depending upon purpose.
Some R&D activities may be regulated directly by FDA according to GxPs, while others may support further work that is submitted to and ultimately reviewed and evaluated by the agency. Research scientists may assist in the investigation of manufacturing or laboratory related failures as well as the design and development of corrective actions for marketed products just as they design and develop new products and associated specifications, manufacturing processes, and controls.

Various best practices apply to research, development, manufacture, and control of products regulated by FDA and include GLPs, GCPs, GTPs, GMPs, and Part 11 (electronic records). FDA regulations and guidelines related to GxPs include, among other things, requirements for standard operating procedures. Deviations from such procedures must be identified, investigated, and corrective actions implemented to prevent recurrence. FDA-regulated companies generally understand that these requirements exist even if they do not always meet current standards in their execution, as evidenced by the content of numerous Warning Letters issued during the past several years.
Simply, a deviation is a difference from what is expected or planned. In the GMP world, as the manufacturing environment is sometimes called, the concept of a deviation is pretty straightforward. Since the GMP world is highly regimented and monitored, expectations are (or should be) clearly stated in procedures and specifications. (For example: Mix for 10 minutes.) Deviations from these expectations are, therefore, relatively easy to identify.

R&D Environment

But what about the R&D environment where experiments and investigations are conducted to obtain additional knowledge or confirm previous results? Clearly, and appropriately in these circumstances, the results cannot or should not be completely predictable. Nonetheless, such work does contain some expectations. For example, if an unknown sample is tested against a blank, a standard, or a control, there are expectations about the characteristics of the blank, standard, or control that will be used to evaluate the results from the unknown sample. As research progresses toward product development, and the body of information about a product builds, the list of expectations grows.
Deviation control in such a setting involves controlling the variables that can be controlled. When sources of variability cannot be identified or controlled, the work history (who, what, when, where, how) should be documented sufficiently to stand as institutional memory and a source of intelligence for future planning and study.

In early conceptual work, it may be appropriate to apply basic laboratory controls, as described below, and fully document the conditions under which work was performed. This documentation is invaluable to a company and other scientists as a product moves from the laboratory into toxicology studies and clinical trials, and provides a sound base from which to evaluate the impact of both subtle and distinct differences in a product through the development phases.

The validity of conclusions made from the interpretation of experimental data and other test results is built upon the level of control of known sources of variability: people, equipment, methodology, and samples. The more these elements are managed to prevent or reduce variability, the more assurance there is that the data accurately reflects the true characteristics of the product.

Recommendations

Basic controls for R&D
Establish a risk-based quality system for R&D work that is designed to control what needs to be controlled, rather than to set controls just for the sake of setting controls.

Establish a quality system in which the levels of control increase as a product progresses through the development phases.
Institute appropriate documentation practices that provide flexibility for scientists but result in a complete and accurate history of purpose and scope of work; how the work was performed; where the work was performed and by whom; and observations, results, or conclusions.
Establish mechanisms whereby related pieces of work can be linked or cross-referenced so that the story of product development can be assembled efficiently.

Basic controls for projects.

Develop and follow an experimental plan (part of a project plan) that sets forth the specific types of controls deemed appropriate according to the purpose and scope of the work that is planned.

Establish appropriate controls over known sources of variability including:

People Establish procedures describing how work should be performed. These procedures may be presented in memoranda, protocols, SOPs, or other forms of documentation. Provide training, instructions, or demonstrations for employees to ensure that procedures are interpreted and will be followed correctly and consistently. It is particularly important to ensure that technique-based skills (e.g., pipetting) are consistently applied. Do not assume that individuals with equivalent years of education and experience will perform critical functions or interpret instructions in the same manner.

Equipment Use clean or new equipment, accessories, and other lab ware; use instruments that are in good working order and calibrated; specify as many equipment operating conditions as possible and document the actual conditions used or observed.
Methodology Describe analytical methods and manufacturing instructions as thoroughly and specifically as possible.

Samples and other materials Describe and characterize samples, controls, and ingredients in manufactured products according to the scope and purpose of the work. At a minimum there should be a record describing: source, appearance, storage, and handling conditions. As development progresses, and specifications are developed, further testing and characterization is expected.

Applying these simple principles and recommendations will improve the quality of R&D work, add credibility and validity to study results, and help to streamline the product development process.
Previous Page Next Page

People Searching On This Page:
  • deviations in pharma
  • Deviation of pharmaceuticals manufacturing process
  • deviation form
  • deviation

Related Pages


B.Pharm/M.Pharm for Drugs Inspector under Directorate of Drugs control

B.Pharm/M.Pharm for Drugs Inspector under Directorate of Drugs control

Jobs | Drug Inspector
Date:
02-Mar-2016  Views: 22304

Online applications are invited from Indian Citizen and such other national as declared eligible by Government of India for recruitment to the 88 post ...
Succes story of Dr Kallam Anji Reddy-Founder of Dr.Reddy's Labs

Succes story of Dr Kallam Anji Reddy-Founder of Dr.Reddy's Labs

News | Pharma Companies
Date:
17-Aug-2014  Views: 2678

Dr Kallam Reddy - The Founder of Dr.Reddy’s ,is the man who has bought life to pharma industry in India by bringing many life saving drugs in to marke ...
Fresher M.Pharm required for Clinical Research Co-ordinator in NIMS

Fresher M.Pharm required for Clinical Research Co-ordinator in NIMS

Jobs | Clinical Research | Hyderabad
Date:
15-Jan-2014  Views: 3622

Applications are invited from suitably qualified and experienced candidates in the prescribed format (to be copied on a plain paper) for the temporary ...
Medical Representative - Cardiovascular/Diabeto Division -Dr. Reddy's

Medical Representative - Cardiovascular/Diabeto Division -Dr. Reddy's

Jobs | Medical Representative
Date:
20-May-2013  Views: 7929

Dr. Reddy's - India today is more than a 200 million dollar venture with presence in almost all major therapeutic areas. Our finished dosage business ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

69  + 7 =     
Comments
People Searched About:
Deviations In Pharma   |   Deviation Of Pharmaceuticals Manufacturing Process   |   Deviation Form   |   Deviation   |  
Google : 136 times | Yahoo : 20 times | Bing : 11 times |